ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Assessment of lower urinary tract dysfunction in women with multiple sclerosis
About authors
1 South Ural State Medical University, Chelyabinsk, Russia
2 National Research Tomsk State University, Tomsk, Russia
3 Medical Rehabilitation Center, Clinical Institute of Brain LLC, Berezovsky, Russia
Correspondence should be addressed: Ekaterina I. Luzanova
Vorovsky, 64, Chelyabinsk, 454092, Russia; ur.xednay@avokihcortse
About paper
Funding: the study was conducted as part of the RSF project No. 23-25-10076.
Author contribution: Luzanova EI — clinical assessment, data analysis and interpretation, manuscript writing; Karpova MI, Abramovskikh OS — study design and supervision, approval of the final version of the manuscript; Chetvernina EA, Zotova MA — laboratory tests; Kupriyanov SV — statistical analysis; Bershadskiy AV — data interpretation.
Compliance with ethical standards: the study was approved by the Ethics Committee of the South Ural State Medical University (protocol No. 8 dated 15 September 2023). All subjects submitted the informed consent to enrollment.
Received: 2024-10-21
Accepted: 2024-11-21
Published online: 2024-12-12
|
Fig. 1. Frequency of storage phase symptoms in women with remittent MS based on the Pelvic Organ Function Questionnaire
Fig. 2. Frequency of voiding symptoms in women with relapsing-remitting MS based on the Pelvic Organ Function Questionnaire
Fig. 3. Frequency of satisfaction with bladder functioning (QOL index) based on the Pelvic Organ Function Questionnaire. * — p < 0.05, χ2 test
Table. Bladder disorder severity in women with remittent MS based on the Neurogenic Bladder Symptom Score (NBSS)
